Joshi A, Gawey L, Rahman M, Ghanshani R, et al. Post-Marketing Safety Analysis of Upadacitinib in Atopic Dermatitis: An FDA Adverse Reporting System (FAERS) Review of Boxed Warning Related Adverse Events. J Am Acad Dermatol 2025 Apr 25:S0190-9622(25)00681.
PMID: 40288538